Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Schacht

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Harvard Business Review|July 23, 2010
Breakthrough ideas for 2010. Getting the drugs we needEric Bonabeau, Alpheus Bingham, Aaron Schacht
Harvard Business Review|January 22, 2010
Breakthrough ideas for 2010.Getting the drugs we needEric Bonabeau, Alpheus Bingham, Aaron Schacht
JAMA Neurology|December 20, 2017
Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical TrialVladimir Skljarevski, Tina M Oakes, Qi Zhang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Harvard Business Review|July 23, 2010
Breakthrough ideas for 2010. Getting the drugs we needEric Bonabeau, Alpheus Bingham, Aaron Schacht
Harvard Business Review|January 22, 2010
Breakthrough ideas for 2010.Getting the drugs we needEric Bonabeau, Alpheus Bingham, Aaron Schacht
JAMA Neurology|December 20, 2017
Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical TrialVladimir Skljarevski, Tina M Oakes, Qi Zhang, et al.
Pageof 1